Literature DB >> 18318754

Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status.

T Kulkarni1, S Gollins, A Maw, P Hobson, R Byrne, D Widdowson.   

Abstract

OBJECTIVE: The aim was to examine the accuracy of magnetic resonance imaging (MRI) in predicting circumferential resection margin (CRM) involvement, T- and N-stage in patients with locally advanced carcinoma of the rectum, who had undergone long-course downstaging chemoradiation (CRT).
METHOD: Patients with rectal cancer were selected for long-course downstaging CRT if their tumour was considered to threaten (< or = 1 mm) or involve the CRM on MRI. Eighty such patients had a repeat MRI at a median of 6 weeks post-CRT followed by surgical excision soon thereafter. The findings on the post-CRT MRI were compared with histological examination of the surgical specimen.
RESULTS: For CRM involvement, post-CRT restaging MRI had an accuracy of 81% (65/80) a sensitivity of 54% (7/13), a specificity of 87% (58/67), a positive predictive value of 44% (7/16) and a negative predictive value of 91% (58/64). Accuracy for T- and N-staging was 43% (34/80) and 78% (62/80), respectively. 38% of T-stages were overstaged and 20% understaged. 4% of N-stages were overstaged and 19% understaged. The 13 patients with histological positive CRM had worse clinical outcomes than the 67 patients with negative CRM in terms of disease-free survival (relative risk of reduced DFS 4.6, P = 0.001) and overall survival (relative risk of death 3.6, P = 0.016).
CONCLUSION: Magnetic resonance imaging has good specificity and negative predictive value for predicting an uninvolved CRM post downstaging CRT in locally advanced rectal cancer although sensitivity and positive predictive value for an involved CRM were unsatisfactory. The shortcomings of MRI stem from poor differentiation of viable tumour from posttreatment changes and inability to identify small nodal and tumour deposits. Clinical correlates in this group of patients have confirmed the importance of achieving a clear CRM at surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18318754     DOI: 10.1111/j.1463-1318.2007.01451.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  18 in total

Review 1.  [Neoadjuvant radiochemotherapy for rectal cancer].

Authors:  W Hohenberger; G Lahmer; R Fietkau; R S Croner; S Merkel; J Göhl; R Sauer
Journal:  Chirurg       Date:  2009-04       Impact factor: 0.955

2.  Clinical significance of magnetic resonance imaging findings in rectal cancer.

Authors:  Charles F Bellows; Bernard Jaffe; Lorenzo Bacigalupo; Salvatore Pucciarelli; Guiseppe Gagliardi
Journal:  World J Radiol       Date:  2011-04-28

3.  Neoadjuvant chemoradiotherapy of the rectal carcinoma - The correlation between the findings on the restaging multiparametric 3T MRI scanning and the surgical findings.

Authors:  Radovan Vojtíšek; Eva Korčáková; Jan Mařan; Ondřej Šorejs; Jindřich Fínek
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

4.  Is there a benefit in using magnetic resonance imaging in the prediction of preoperative neoadjuvant therapy response in locally advanced rectal cancer?

Authors:  Lian-Ming Wu; Jiong Zhu; Jiani Hu; Yan Yin; Hai-Yan Gu; Jia Hua; Jie Chen; Jian-Rong Xu
Journal:  Int J Colorectal Dis       Date:  2013-03-21       Impact factor: 2.571

5.  Can CRM Status on MRI Predict Survival in Rectal Cancers: Experience from the Indian Subcontinent.

Authors:  Mihir Chandarana; Supreeta Arya; Jean-Louis de Menezes; Reena Engineer; Vikas Ostwal; Prachi Patil; Suman Kumar; Rohit Dusane; Ashwin D'souza; Avanish Saklani
Journal:  Indian J Surg Oncol       Date:  2019-02-21

6.  Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.

Authors:  Ly Do; Nisar Syed; Ajmel Puthawala; Samar Azawi; Imad Shbeeb; I-Yeh Gong
Journal:  Gastrointest Cancer Res       Date:  2011-05

7.  MRI at Restaging After Neoadjuvant Therapy for Rectal Cancer Overestimates Circumferential Resection Margin Proximity as Determined by Comparison With Whole-Mount Pathology.

Authors:  Jonathan B Yuval; Hannah M Thompson; Canan Firat; Floris S Verheij; Maria Widmar; Iris H Wei; Emmanouil Pappou; J Joshua Smith; Martin R Weiser; Philip B Paty; Garrett M Nash; Jinru Shia; Marc J Gollub; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2022-04-01       Impact factor: 4.585

8.  Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer.

Authors:  Wijnand J Alberda; Helene P N Dassen; Roy S Dwarkasing; François E J A Willemssen; Anne E M van der Pool; Johannes H W de Wilt; Jacobus W A Burger; Cornelis Verhoef
Journal:  Int J Colorectal Dis       Date:  2012-09-22       Impact factor: 2.571

9.  Circumferential resection margins of rectal tumours post-radiotherapy: how can MRI aid surgical planning?

Authors:  E R McGlone; V Shah; C Lowdell; D Blunt; P Cohen; P M Dawson
Journal:  Tech Coloproctol       Date:  2014-07-19       Impact factor: 3.781

10.  Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review.

Authors:  Michael R Torkzad; Lars Påhlman; Bengt Glimelius
Journal:  Insights Imaging       Date:  2010-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.